VAS-2 Vasectomy With the Vax-X
NCT00663533 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2014-12-03
Summary
The purpose of this research study is to study an experimental vasectomy device called the Vas-X. This is an experimental study of this new approach to vasectomy.
Conditions
- Healthy
Interventions
- DEVICE
-
Vas-X
mechanical vasectomy device
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John Amory · University of Washington
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2008-07-31
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4
NCT01120535 ·Status: COMPLETED ·Phase: PHASE3
-
Crux Biomedical IVC Filter - Evaluation of the Crux Inferior Vena Cava Filter System (Retrieve)
NCT00605332 ·Status: COMPLETED ·Phase: PHASE2
-
SEBBIN Silicone Gel-filled Testicular Implants
NCT04968470 ·Status: RECRUITING
-
Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure
NCT02837744 ·Status: COMPLETED
-
Novel Device for Reducing Catheter-Related Infections
NCT00878683 ·Status: WITHDRAWN ·Phase: NA
-
Vialize Use for the Reduction of Vascular Groin Incisional Dehiscence and Infection
NCT06032949 ·Status: COMPLETED ·Phase: NA
-
Investigation of New Intermittent Catheter Swelling Media in Healthy Volunteers
NCT04633291 ·Status: COMPLETED ·Phase: NA
-
The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
NCT02746419 ·Status: WITHDRAWN ·Phase: NA
-
Veinplicity for Improved Venous Access: The VIVA Trial
NCT03752632 ·Status: TERMINATED ·Phase: PHASE3
-
X-Seal EU Post-Market Clinical Follow-Up Protocol
NCT02406612 ·Status: COMPLETED ·Phase: NA
-
First In-human Use of SETALUM™ Sealant: The BlueSeal Clinical Study
NCT03374735 ·Status: COMPLETED ·Phase: NA
-
Transvaginal Treatment of Symptomatic Cystocele Grade II-III
NCT02272322 ·Status: UNKNOWN
-
Study to Evaluate Safety & Effectiveness of Vascular Sealant System
NCT00439309 ·Status: TERMINATED ·Phase: NA
-
Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™
NCT03426943 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients
NCT06770374 ·Status: RECRUITING ·Phase: NA
-
ThrombX Retriever for Acute Ischemic Stroke Trial
NCT05270122 ·Status: UNKNOWN ·Phase: NA
-
A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters
NCT05386342 ·Status: RECRUITING ·Phase: NA
-
Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter
NCT00196118 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating the Clinical Performance of the ViaValve™ Safety IV Catheter
NCT02119351 ·Status: COMPLETED ·Phase: NA
-
Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)
NCT01539343 ·Status: COMPLETED ·Phase: PHASE2
-
EFFEXTS OF THE CLEANSWEEP SUCTION CATHETER
NCT03486002 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of the URECA CTO Device
NCT04385381 ·Status: TERMINATED ·Phase: NA
-
Clinical Trial of the WC360 SiteSeal Adjunctive Compression Device Following Interventional Endovascular Procedures
NCT03234894 ·Status: UNKNOWN ·Phase: NA
-
Innovative Central Line Securement Device in the Pediatric Population
NCT04522778 ·Status: TERMINATED ·Phase: NA
-
Axium™ MicroFX™ for Endovascular Repair of IntraCranial Aneurysm-A Multicenter Study
NCT01323439 ·Status: COMPLETED